STAND Against Emerging Opioids Act

# STAND Against Emerging Opioids Act (HR 3520) - Summary **What the Bill Would Do** This bill aims to address the opioid crisis by targeting newly emerging synthetic opioids that aren't yet controlled under federal law. The legislation would give federal agencies tools to quickly classify and regulate dangerous opioid compounds before they become widespread public health threats. By streamlining the process for identifying and controlling new synthetic opioids, the bill seeks to prevent drug manufacturers from circumventing existing drug laws by constantly creating slight chemical variations of banned substances. **Who It Affects and Key Provisions** The bill would impact law enforcement agencies, the DEA, pharmaceutical companies, and communities affected by opioid addiction.

It likely includes provisions for faster designation of new opioids as controlled substances, potentially with temporary emergency scheduling authority. The legislation is designed to close gaps in current regulations that allow illicit drug producers to stay ahead of existing drug control laws. **Current Status** As of now, HR 3520 is in committee and has not yet been brought to a full vote in the House. The bill was introduced in the 119th Congress by Representative Jimmy Panetta (D-California).